Cancer Gene Therapy

Aims & Scope

Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer.

The journal publishes original laboratory and clinical research papers, case reports and review articles.

Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.

Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research.

Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5
2024	4.80

SJR (SCImago Journal Rank)

Year	Value
2024	1.727

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	101

Journal Rank

Year	Value
2024	1851

Journal Citation Indicator

Year	Value
2024	2291

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms

  Citation: 632

  Authors: Rong En, Emma K., Han Chong

• Mechanisms of resistance to TRAIL-induced apoptosis in cancer

  Citation: 573

  Authors: Lidong, Bingliang

• Key chemokines direct migration of immune cells in solid tumors

  Citation: 404

  Authors: Karan, Venu G., Teresa S.

• The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin

  Citation: 296

  Authors: V, E D, A, G, D

• Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

  Citation: 287

  Authors: Michael J, Henry C, Laurence C, Carol E, Claude E, Peter A, Albert J, Edmund C

• Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

  Citation: 280

  Authors: John, Casey, Neil, Joseph, Jennifer, Craig, Robert, Ann, Caroline, Mario

• siRNA-based approaches in cancer therapy

  Citation: 279

  Authors: G R

• MicroRNA and drug resistance

  Citation: 254

  Authors: J, C, C

• New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles

  Citation: 234

  Authors: M A, N, A, H, P, A, L K, S R, H, S, J

• Cancer-associated fibroblasts: overview, progress, challenges, and directions

  Citation: 225

  Authors: Qinrong, Ruping, Xin, Wenju, Yiming, Zongliu, Yunqiang, Chunhui, Ruhong

---